CDK11 p58 protein kinase activity is associated with Bcl-2 down-regulation in pro-apoptosis pathway
Xiaojing Yun,Yihong Wu,Luyang Yao,Hongliang Zong,Yi Hong,Jianhai Jiang,Junwu Yang,Zhou Zhang,Jianxin Gu
DOI: https://doi.org/10.1007/s11010-007-9502-x
IF: 3.842
2007-01-01
Molecular and Cellular Biochemistry
Abstract:CDK11 p58 , a G2/M-specific protein kinase, has been shown to be associated with apoptosis in many cell lines, with largely unknown mechanisms. Our previous study proved that CDK11 p58 -enhanced cycloheximide (CHX)-induced apoptosis in SMMC-7721 hepatocarcinoma cells. Here we report for the first time that ectopic expression of CDK11 p58 down-regulates Bcl-2 expression and its Ser70, Ser87 phosphorylation in CHX-induced apoptosis in SMMC-7721 cells. Overexpression of Bcl-2 counteracts the pro-apoptotic activity of CDK11 p58 . Furthermore, we confirm that the kinase activity of CDK11 p58 is essential to the down-regulation of Bcl-2 as well as apoptosis. Taken together, these results demonstrate that CDK11 p58 down-regulates Bcl-2 in pro-apoptosis pathway depending on its kinase activity, which elicits survival signal in hepatocarcinoma cells.
What problem does this paper attempt to address?